These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21240382)

  • 41. Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
    Tabone MD; Brugières L; Piperno-Neumann S; Selva MA; Marec-Bérard P; Pacquement H; Lervat C; Corradini N; Gentet JC; Couderc R; Chevance A; Mahier-Ait Oukhatar C; Entz-Werle N; Blay JY; Le Deley MC
    BMC Cancer; 2017 Jun; 17(1):419. PubMed ID: 28619014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prognostic value of expression of FASE, HER-2/neu, bcl-2 and p53 in stage I non-small cell lung cancer].
    Wang Y; Zhang XR; Fu J; Tan W; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):369-72. PubMed ID: 15312350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.
    Fu HL; Shao L; Wang Q; Jia T; Li M; Yang DP
    Tumour Biol; 2013 Dec; 34(6):3817-21. PubMed ID: 24014053
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Expression of hypoxia-inducible factor 1α in osteosarcoma and its value in predicting chemosensitivity].
    Chen Y; Wang CM; Shi YQ; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):899-904. PubMed ID: 23336375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma.
    Pan J; Tang T; Xu L; Lu JJ; Lin S; Qiu S; Chen G; K Tham IW
    Head Neck; 2013 Sep; 35(9):1238-47. PubMed ID: 22972415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.
    Sulzbacher I; Birner P; Trieb K; Lang S; Chott A
    Virchows Arch; 2002 Oct; 441(4):345-9. PubMed ID: 12404059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The expression of epidermal growth factor receptor and its downstream signaling molecules in osteosarcoma.
    Do SI; Jung WW; Kim HS; Park YK
    Int J Oncol; 2009 Mar; 34(3):797-803. PubMed ID: 19212684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas.
    Gupta D; Shidham V; Holden J; Layfield L
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):267-74. PubMed ID: 11127918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer.
    Nielsen JS; Jakobsen E; Hølund B; Bertelsen K; Jakobsen A
    Int J Gynecol Cancer; 2004; 14(6):1086-96. PubMed ID: 15571614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An immunostaining panel for diagnosis of malignancy in mucinous tumors of the pancreas.
    Zhao J; Liang SX; Savas L; Banner BF
    Arch Pathol Lab Med; 2001 Jun; 125(6):765-9. PubMed ID: 11371228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma.
    Handa A; Tokunaga T; Tsuchida T; Lee YH; Kijima H; Yamazaki H; Ueyama Y; Fukuda H; Nakamura M
    Int J Oncol; 2000 Aug; 17(2):291-5. PubMed ID: 10891538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
    Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
    Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
    Kim YJ; Kim MA; Im SA; Kim TM; Kim DW; Yang HK; Heo DS; Lee KU; Choe KJ; Kim NK; Kim TY; Kim WH; Bang YJ
    Cancer Invest; 2008 Mar; 26(2):152-8. PubMed ID: 18259945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
    Sha D; He YJ
    Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenoid cystic carcinoma of the trachea and bronchus--a clinicopathologic study with DNA flow cytometric analysis and oncogene expression.
    Lin CM; Li AF; Wu LH; Wu YC; Lin FC; Wang LS
    Eur J Cardiothorac Surg; 2002 Oct; 22(4):621-5. PubMed ID: 12297183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic values of p53 and HER-2/neu coexpression in invasive bladder cancer in Taiwan.
    Tsai YS; Tzai TS; Chow NH; Yang WH; Tong YC; Lin JS; Chang CC; Cheng HL; Lin YM
    Urol Int; 2003; 71(3):262-70. PubMed ID: 14512646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma.
    Lee YH; Tokunaga T; Oshika Y; Suto R; Yanagisawa K; Tomisawa M; Fukuda H; Nakano H; Abe S; Tateishi A; Kijima H; Yamazaki H; Tamaoki N; Ueyama Y; Nakamura M
    Eur J Cancer; 1999 Jul; 35(7):1089-93. PubMed ID: 10533453
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
    Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
    Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Apoptosis-related gene expression and its clinical significance of human osteosarcoma].
    Wu X; Chen ZR; Zhang GJ
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):678-81. PubMed ID: 15777507
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
    Zou P; Ding J; Fu S
    Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.